BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35625705)

  • 1. Different Effects of Valproic Acid on
    Damanskienė E; Balnytė I; Valančiūtė A; Alonso MM; Stakišaitis D
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Comparative Experimental Study of Sodium and Magnesium Dichloroacetate Effects on Pediatric PBT24 and SF8628 Cell Glioblastoma Tumors Using a Chicken Embryo Chorioallantoic Membrane Model and on Cells In Vitro.
    Damanskienė E; Balnytė I; Valančiūtė A; Lesauskaitė V; Alonso MM; Stakišaitis D
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Different Temozolomide Effects on Tumorigenesis Mechanisms of Pediatric Glioblastoma PBT24 and SF8628 Cell Tumor in CAM Model and on Cells In Vitro.
    Damanskienė E; Balnytė I; Valančiūtė A; Alonso MM; Preikšaitis A; Stakišaitis D
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of valproic acid on SLC5A8 expression in gonad-intact and gonadectomized rat thymocytes.
    Juknevičienė M; Balnytė I; Valančiūtė A; Stanevičiūtė J; Sužiedėlis K; Stakišaitis D
    Int J Immunopathol Pharmacol; 2022; 36():20587384211051954. PubMed ID: 35120418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic Acid Inhibits NA-K-2CL Cotransporter RNA Expression in Male But Not in Female Rat Thymocytes.
    Juknevičienė M; Balnytė I; Valančiūtė A; Lesauskaitė V; Stanevičiūtė J; Curkūnavičiūtė R; Stakišaitis D
    Dose Response; 2019; 17(2):1559325819852444. PubMed ID: 31210756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effectiveness of Dichloroacetate on Human Glioblastoma Xenograft Growth Depends on Na+ and Mg2+ Cations.
    Stakišaitis D; Damanskienė E; Curkūnavičiūtė R; Juknevičienė M; Alonso MM; Valančiūtė A; Ročka S; Balnytė I
    Dose Response; 2021; 19(1):1559325821990166. PubMed ID: 33716589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples.
    Berendsen S; Frijlink E; Kroonen J; Spliet WGM; van Hecke W; Seute T; Snijders TJ; Robe PA
    Neurooncol Adv; 2019; 1(1):vdz025. PubMed ID: 32642660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dissection of the valproic acid effects on glioma cells.
    Hoja S; Schulze M; Rehli M; Proescholdt M; Herold-Mende C; Hau P; Riemenschneider MJ
    Oncotarget; 2016 Sep; 7(39):62989-63002. PubMed ID: 27556305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
    Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
    J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
    Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
    J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
    Krauze AV; Myrehaug SD; Chang MG; Holdford DJ; Smith S; Shih J; Tofilon PJ; Fine HA; Camphausen K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):986-992. PubMed ID: 26194676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.
    Das CM; Aguilera D; Vasquez H; Prasad P; Zhang M; Wolff JE; Gopalakrishnan V
    J Neurooncol; 2007 Nov; 85(2):159-70. PubMed ID: 17534580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia.
    Hyde TM; Lipska BK; Ali T; Mathew SV; Law AJ; Metitiri OE; Straub RE; Ye T; Colantuoni C; Herman MM; Bigelow LB; Weinberger DR; Kleinman JE
    J Neurosci; 2011 Jul; 31(30):11088-95. PubMed ID: 21795557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular Effects of the Antiepileptic Drug Valproic Acid in Glioblastoma.
    Eckert M; Klumpp L; Huber SM
    Cell Physiol Biochem; 2017; 44(4):1591-1605. PubMed ID: 29212069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells.
    Papi A; Ferreri AM; Rocchi P; Guerra F; Orlandi M
    Anticancer Res; 2010 Feb; 30(2):535-40. PubMed ID: 20332466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuronal K
    Kursan S; McMillen TS; Beesetty P; Dias-Junior E; Almutairi MM; Sajib AA; Kozak JA; Aguilar-Bryan L; Di Fulvio M
    Sci Rep; 2017 May; 7(1):1732. PubMed ID: 28496181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.
    Tseng JH; Chen CY; Chen PC; Hsiao SH; Fan CC; Liang YC; Chen CP
    Oncotarget; 2017 Feb; 8(9):14666-14679. PubMed ID: 28108734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.
    Alvarez-Breckenridge CA; Yu J; Price R; Wei M; Wang Y; Nowicki MO; Ha YP; Bergin S; Hwang C; Fernandez SA; Kaur B; Caligiuri MA; Chiocca EA
    J Virol; 2012 Apr; 86(8):4566-77. PubMed ID: 22318143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells.
    Thotala D; Karvas RM; Engelbach JA; Garbow JR; Hallahan AN; DeWees TA; Laszlo A; Hallahan DE
    Oncotarget; 2015 Oct; 6(33):35004-22. PubMed ID: 26413814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function.
    Coothankandaswamy V; Elangovan S; Singh N; Prasad PD; Thangaraju M; Ganapathy V
    Biochem J; 2013 Feb; 450(1):169-78. PubMed ID: 23167260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.